Skip to content

On-Demand Webinar: Advancing Neuroinflammation Research with iPSC-Derived Microglia and Automated Assays for Drug Discovery

Home > Webinars > Current page
On-Demand Neuroinflammation Research Webinar

Are current neuroinflammation models constraining your research?

Watch our on-demand webinar to explore how Arctoris, EditCo and Brainxell are leveraging CRISPR-edited, iPSC-derived human microglia in automated, multiplexed assays to enhance disease modeling and drug discovery. This approach integrates human-relevant cellular models with mid-throughput automation and comprehensive neuroinflammatory readouts including phagocytosis, cytokine response, and inflammasome modulation.

Key Benefits:

  • More Predictive: Human microglia models improve translational relevance
  • More Efficient: Miniaturized, multiplexed assays optimize resources
  • More Scalable: Automated workflows deliver reproducible, high-content data

Related poster:

Characterisation of TREM2 R47H iPSC-Derived Microglia, & Assessmentof Their Suitability for NLRP3 Inflammasome Drug Discovery

Please provide the following information to access the webinar recording.